MedPath

Peking University Third Hospital (Peking University Third Clinical Medical College)

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Nimotuzumab Combined With Chemoradiotherapy Versus Chemoradiotherapy for Local Advanced Cervical Squamous Cell Carcinoma

Not Applicable
Not yet recruiting
Conditions
Cervical Squamous Cell Carcinoma
Interventions
Radiation: External-beam radiation
Radiation: Brachytherapy
First Posted Date
2020-12-22
Last Posted Date
2020-12-22
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
286
Registration Number
NCT04678791
Locations
🇨🇳

Peking University 3rd Hospital, Beijing, Beijng, China

the Efficacy and Safety of CLAE in R/R T-ALL/LBL

Conditions
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
First Posted Date
2020-12-22
Last Posted Date
2020-12-22
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
50
Registration Number
NCT04679506

Study on Curative Effect and Mechanism of Acupuncture on Neuropathic Pain in Dry Eye Disease

Not Applicable
Completed
Conditions
Dry Eye
Interventions
First Posted Date
2020-12-16
Last Posted Date
2022-11-23
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
20
Registration Number
NCT04668131
Locations
🇨🇳

Peking University Third Hospital, Beijing, China

The Effect of 3% Diquafosol Ophthalmic Solution on Visual Display Terminal-associated Dry Eye

Phase 4
Conditions
Dry Eye Syndromes
Computer Vision Syndrome
Asthenopia
Interventions
First Posted Date
2020-12-16
Last Posted Date
2022-06-01
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
68
Registration Number
NCT04668118
Locations
🇨🇳

Peking University Third Hospital, Beijing, Beijing, China

Correlation Study of Corneal Nerve Changes and Dry Eye in Contact Lens Wearers

Completed
Conditions
Dry Eye
Contact Lens Complication
Interventions
Other: contact lens
First Posted Date
2020-12-11
Last Posted Date
2022-06-01
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
60
Registration Number
NCT04663529
Locations
🇨🇳

Peking University Third Hospital, Beijing, Beijing, China

The Efficacy of Different Immobilization Times After Achilles Tendon Rupture Surgery

Not Applicable
Conditions
Achilles Tendon Rupture
Interventions
Procedure: immobilization duration
First Posted Date
2020-12-11
Last Posted Date
2020-12-11
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
240
Registration Number
NCT04663542
Locations
🇨🇳

Peking University Third Hospital, Beijing, Beijing, China

PGT-A in Screening of Embryos in the Treatment of Unexplained Recurrent Miscarriage

Completed
Conditions
Recurrent Early Pregnancy Loss
First Posted Date
2020-11-25
Last Posted Date
2020-11-25
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
69
Registration Number
NCT04643938
Locations
🇨🇳

Center of Reproductive Medicine, Peking University Third Hospital, Beijing, Haidian, China

Live Birth Rate in Patients With Unexplained Recurrent Pregnancy Loss

Active, not recruiting
Conditions
Preimplantation Genetic Screening
Recurrent Pregnancy Loss
Interventions
Procedure: Preimplantation Genetic Screening(exposure)
First Posted Date
2020-11-09
Last Posted Date
2020-11-09
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
400
Registration Number
NCT04621773
Locations
🇨🇳

Center of Reproductive Medicine, Peking University Third Hospital, Beijing, Haidian, China

A Study of GC019F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL

Phase 1
Not yet recruiting
Conditions
B-cell Acute Lymphoblastic Leukemia
Interventions
Biological: GC019F
First Posted Date
2020-10-20
Last Posted Date
2020-10-20
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
12
Registration Number
NCT04595162

National Nurses Health Cohort Study (NNHS): a Web-based Ambispective Cohort Study in China

Conditions
Nurse Health
Interventions
Other: Observational
First Posted Date
2020-10-01
Last Posted Date
2020-12-28
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
2000
Registration Number
NCT04572347
© Copyright 2025. All Rights Reserved by MedPath